PATENT CLAIM ANALYSIS

Application Number: 15875192
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "061000"]

Abstract:
Provided are compositions related to HSD17B13 variants, including nucleic acid molecules and polypeptides related to variants of HSD17B13, and cells comprising those nucleic acid molecules and polypeptides. Also provided are methods related to HSD17B3 variants. Such methods include methods for detecting the presence of the HSD17B13 rs72613567 variant in a biological sample comprising genomic DNA, for detecting the presence or levels of any one of variant HSD17B13 Transcripts C, D, E, F, G, and H, and particularly D, in a biological sample comprising mRNA or cDNA, or for detecting the presence or levels of any one of variant HSD17B13 protein Isoforms C, D, E, F, G, or H, and particularly D, in a biological sample comprising protein. Also provided are methods for determining a subject's susceptibility to developing a liver disease or of diagnosing a subject with liver disease.

Claim (Index 16):
The polypeptide of  claim 15 , wherein the polypeptide comprises the amino acid sequence of HSD17B13 Isoform D (SEQ ID NO:42).

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 2.6129
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12444903', '13974007', '12081101', '12339877', '11405322']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6449151946718956
- 35 USC 102 Novelty (BERT): 0.5124849609208616
- Combined Prediction Score: 0.6316721712967922
- Mean Citation Score: 273.25583
- Max Citation Score: 288.2544
- Similarity Product: 191.5010813006401

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test